Clinical Trials

600 enrolled

Disease, Melanoma

NCT02232516 2024-04-10

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

30 enrolled 17 charts

DermatologicLymphoid

Immunoblastic Lymphadenopathy, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

NCT06342297 2024-04-02

Dermatoscopy Guided Resection for Skin Cancer

400 enrolled

Margins of Excision, Carcinoma, Basal Cell

NCT05311618 2024-04-01

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

71 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06320353 2024-03-20

Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma

Phase 3 Unknown

266 enrolled

Melanoma, Neoplasms

NCT06321640 2024-03-20

POSITive

BreastDermatologicGastrointestinalGenitourinaryHead & NeckThoracic

265 enrolled

Breast Neoplasms, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT05421377 2024-03-12

EvaLymph-Leg2

120 enrolled

Skin Neoplasms, Urogenital Neoplasms

NCT06307093 2024-03-12

Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

DermatologicHead & NeckThoracic

90 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Lung Neoplasms, Melanoma, Neoplasms

NCT06299878 2024-03-08

CRISTINA

72 enrolled

Melanoma

NCT06206681 2024-03-07

Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors

1,000 enrolled

Eyelid Neoplasms, Keratosis, Nevus, Pigmented, Xanthomatosis

NCT04544748 2024-03-06

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

DermatologicGenitourinaryThoracic

48 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urologic Neoplasms

NCT06280040 2024-03-06

Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma

20 enrolled

Uveal Melanoma

NCT06294379 2024-03-05

Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy

150 enrolled

Melanoma

NCT06284512 2024-02-29

Uveal Melanoma - Comparative Study

50 enrolled

Uveal Melanoma

NCT05942794 2024-02-28

Identification of Oral Lesions Through an Autofluorescence System

200 enrolled

DermatologicHead & Neck

Carcinoma, Squamous Cell, Keratosis, Leukoplakia, Oral, Lichen Planus, Mouth Diseases, Mouth Neoplasms, Lichen Planus, Oral

NCT06151847 2024-02-28

Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma

12 enrolled

Melanoma

NCT06281912 2024-02-28

MELCAYA

70 enrolled

Melanoma

NCT06271603 2024-02-22

ECOBASO

704 enrolled

Carcinoma, Basal Cell

NCT06273709 2024-02-22

Remote Assessment of OCT Scans for BCC Detection

120 enrolled

Carcinoma, Basal Cell

NCT05135715 2024-02-20

A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

50 enrolled

Melanoma

NCT05817279 2024-02-16

AI-aided Optical Coherence Tomography for the Detection of Basal Cell Carcinoma

124 enrolled

Carcinoma, Basal Cell

NCT06024629 2024-02-16

cOCT Versus LC-OCT for Diagnosing Basal Cell Carcinoma: a Diagnostic Cohort Study

197 enrolled

Carcinoma, Basal Cell

NCT06254547 2024-02-12

Leaderboard Influence on Self-Regulated Training in a Gamified Dermoscopy Training App

150 enrolled

Melanoma, Skin Neoplasms

NCT04702854 2024-02-09

BMUMM

60 enrolled

Melanoma

NCT04137900 2024-02-05

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

DermatologicLymphoidThoracic

499 enrolled

Carcinoma, Non-Small-Cell Lung, Lymphoma, Melanoma, Neoplasm Metastasis

NCT06239623 2024-02-02

ERK Inhibitor JSI-1187 in Advanced Solid Tumors

60 enrolled

Melanoma

NCT06236360 2024-02-01

MINI-MD

30 enrolled

Melanoma, Neoplasm Metastasis

NCT06227416 2024-01-26

Skin Tumor Biomarkers by Mass Spectrometry Imaging

300 enrolled

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Skin Neoplasms

NCT03068624 2024-01-25

Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma

34 enrolled

Uveal Melanoma

NCT00368615 2024-01-23

Melanoma

20 enrolled

Melanoma

NCT06145464 2024-01-17

Shadow4All

60 enrolled

Literacy, Skin Neoplasms

NCT06207747 2024-01-17

Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients

70 enrolled

Melanoma

NCT04253080 2024-01-09

ENZYMELA

170 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

NCT04720768 2024-01-05

CELEBRATE

78 enrolled

Melanoma, Neoplasm Metastasis

NCT06150144 2024-01-02

The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma

Phase 3 Unknown

40 enrolled

Carcinoma, Basal Cell

NCT05022901 2023-12-21

An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma

Phase 3 Unknown

30 enrolled

Uveal Melanoma

NCT03840928 2023-12-13

PatientSpot Formerly Known as ArthritisPower

CNSDermatologicOtherThoracic

40,000 enrolled

Intervertebral disc disease, Undifferentiated Connective Tissue Diseases, Axial Spondyloarthritis, Alopecia, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Angina, Unstable, Arrhythmias, Cardiac, Arthritis, Juvenile, Arthritis, Rheumatoid, Asthma, Ataxia, Brain Neoplasms, Intracranial Aneurysm, Cluster Headache, Crohn Disease, Cystic Fibrosis, Dermatomyositis, Diabetes Mellitus, Hyperostosis, Diffuse Idiopathic Skeletal, Eczema, Epilepsy, Fibromyalgia, Gout, Craniocerebral Trauma, Headache, Heart Defects, Congenital, Heart Failure, Heart Valve Diseases, Hydrocephalus, Hypertension, Lung Neoplasms, Meningitis, Multiple Sclerosis, Muscular Dystrophies, Myocardial Infarction, Myositis, Obesity, Osteoarthritis, Osteoporosis, Parkinson Disease, Polychondritis, Relapsing, Polymyalgia Rheumatica, Psoriasis, Sleep Apnea Syndromes, Spinal Cord Injuries, Spondylitis, Ankylosing, Giant Cell Arteritis, Granulomatosis with Polyangiitis, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Polymyositis, Tension-Type Headache, Guillain-Barre Syndrome, Bell Palsy, Stroke, Neurocutaneous Syndromes, Pulmonary Disease, Chronic Obstructive, Scleroderma, Diffuse, Peripheral Arterial Disease

NCT03638375 2023-12-12

ACTME

34 enrolled

Melanoma, Drug-Related Side Effects and Adverse Reactions

NCT02557321 2023-11-21

PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma

50 enrolled

Melanoma

NCT04485442 2023-11-21

Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face

100 enrolled

Melanoma, Skin Neoplasms

NCT05451680 2023-11-21

Negative-pressure Wound Therapy on Full-thickness Skin Grafts of the Lower Leg

20 enrolled

Skin Neoplasms

NCT05456334 2023-11-21

New Treatments for Actinic Keratoses of the Scalp

120 enrolled

Keratosis, Actinic

NCT02977052 2023-11-15

OpACIN-neo

186 enrolled

Melanoma

NCT05234658 2023-11-08

Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery

21 enrolled

Carcinoma, Basal Cell

NCT05094804 2023-11-02

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents